Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.46 USD 2.04% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Relative Value

The Relative Value of one AMPH stock under the Base Case scenario is 71.45 USD. Compared to the current market price of 45.46 USD, Amphastar Pharmaceuticals Inc is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMPH Relative Value
Base Case
71.45 USD
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
46
vs Industry
39
Median 3Y
3.4
Median 5Y
2.9
Industry
2.5
Forward
2.9
vs History
90
vs Industry
33
Median 3Y
19
Median 5Y
19.3
Industry
21.9
Forward
11.2
vs History
93
vs Industry
35
Median 3Y
13.3
Median 5Y
14.5
Industry
16.5
vs History
34
vs Industry
35
Median 3Y
12.4
Median 5Y
13.5
Industry
23.6
vs History
39
vs Industry
27
Median 3Y
3.3
Median 5Y
2.7
Industry
2.1
vs History
31
vs Industry
34
Median 3Y
3.5
Median 5Y
2.8
Industry
2.6
Forward
3.4
vs History
33
vs Industry
33
Median 3Y
6.6
Median 5Y
6.3
Industry
5.2
vs History
90
vs Industry
36
Median 3Y
11.9
Median 5Y
14.3
Industry
13.3
Forward
8.3
vs History
84
vs Industry
36
Median 3Y
14.7
Median 5Y
17.8
Industry
16.6
Forward
9.3
vs History
73
vs Industry
34
Median 3Y
13.6
Median 5Y
14
Industry
15.6
vs History
87
vs Industry
25
Median 3Y
18
Median 5Y
19.1
Industry
19.1
vs History
49
vs Industry
39
Median 3Y
2.4
Median 5Y
2
Industry
1.9

Multiples Across Competitors

AMPH Competitors Multiples
Amphastar Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
2.2B USD 3 13.9 9.5 11.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top